Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-21

Clinical Trial Update: A Clinical Study Investigating the Effects of a Dentifrice Containing 0.454% Stannous Fluoride on Gingivitis Treatment and Plaque Reduction When Used Twice Daily for 12 Weeks [NA]

View source ↗

Summary

This completed clinical trial evaluated a dentifrice containing 0.454% stannous fluoride for gingivitis treatment and plaque reduction with twice-daily use over…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stannous fluoride dentifrice (0.454%) (stannous fluoride toothpaste)

Snippet

Sponsor: HALEON | Conditions: Gingivitis | NA | Status: COMPLETED | Results posted: 2025-03-21